Rigel Pharmaceuticals Correlations
RIGL Stock | USD 20.54 0.34 1.68% |
The current 90-days correlation between Rigel Pharmaceuticals and Fortress Biotech is -0.05 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rigel Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rigel Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Rigel Pharmaceuticals Correlation With Market
Very weak diversification
The correlation between Rigel Pharmaceuticals and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Rigel |
Moving together with Rigel Stock
0.73 | PLX | Protalix Biotherapeutics | PairCorr |
0.73 | WM | Waste Management | PairCorr |
0.85 | GE | GE Aerospace | PairCorr |
0.68 | CSCO | Cisco Systems | PairCorr |
0.88 | MMM | 3M Company | PairCorr |
0.61 | T | ATT Inc Sell-off Trend | PairCorr |
0.66 | JPM | JPMorgan Chase | PairCorr |
0.66 | IBM | International Business | PairCorr |
Moving against Rigel Stock
0.7 | CDIO | Cardio Diagnostics | PairCorr |
0.67 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.56 | ELVN | Enliven Therapeutics | PairCorr |
0.51 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.5 | SCLX | Scilex Holding | PairCorr |
0.44 | CDIOW | Cardio Diagnostics | PairCorr |
0.6 | MRK | Merck Company | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rigel Stock performing well and Rigel Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rigel Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
FBIO | 2.67 | (0.11) | 0.00 | (0.65) | 0.00 | 5.19 | 22.19 | |||
RVPH | 5.07 | (0.78) | 0.00 | (0.27) | 0.00 | 11.05 | 39.67 | |||
CTIC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
OCUP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NBRV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
EIGR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PIRS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CDTX | 3.36 | 0.12 | 0.02 | 0.09 | 5.43 | 6.73 | 22.90 | |||
XFOR | 6.27 | (0.67) | 0.00 | (1.77) | 0.00 | 10.87 | 68.45 | |||
MREO | 2.65 | (0.57) | 0.00 | (0.84) | 0.00 | 6.16 | 20.77 |
Rigel Pharmaceuticals Corporate Management
Raymond JD | General VP | Profile | |
Tarek Sallam | Vice Marketing | Profile | |
David Santos | Executive Officer | Profile | |
Julie Patel | Senior Resources | Profile |